cached image

Ed Harlow - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Cancer Biology
Website:
https://bcmp.hms.harvard.edu/person/faculty/ed-harlow

126/237 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Li W, Ai N, Wang S, Bhattacharya N, Vrbanac V, Collins M, Signoretti S, Hu Y, Boyce FM, Gravdal K, Halvorsen OJ, Nalwoga H, Akslen LA, Harlow E, Watnick RS. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 111: 1521-6. PMID 24434559 DOI: 10.1073/Pnas.1320638111  0.33
2014 Ai N, Hulsurkar M, Akslen L, Watnick R, Harlow E, Li W. Abstract LB-189: GRK3 is essential for metastatic cells and promotes prostate cancer progression Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-189  0.312
2013 Demarest SJ, Gardner J, Vendel MC, Ailor E, Szak S, Huang F, Doern A, Tan X, Yang W, Grueneberg DA, Richards EJ, Endege WO, Harlow E, Koopman LA. Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines. Biochemistry. 52: 3102-18. PMID 23570341 DOI: 10.1021/bi301588c  0.355
2012 Ai N, Harlow E, Li W. Abstract LB-90: Essential kinases for human metastatic cells pertaining to c-Met signaling Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-90  0.346
2011 Tschöp K, Conery AR, Litovchick L, Decaprio JA, Settleman J, Harlow E, Dyson N. A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes & Development. 25: 814-30. PMID 21498571 DOI: 10.1101/Gad.2000211  0.639
2010 Conery AR, Sever S, Harlow E. Nucleoside diphosphate kinase Nm23-H1 regulates chromosomal stability by activating the GTPase dynamin during cytokinesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 15461-6. PMID 20713695 DOI: 10.1073/Pnas.1010633107  0.303
2010 Conery AR, Harlow E. High-throughput screens in diploid cells identify factors that contribute to the acquisition of chromosomal instability. Proceedings of the National Academy of Sciences of the United States of America. 107: 15455-60. PMID 20713694 DOI: 10.1073/pnas.1010627107  0.307
2010 Baldwin A, Grueneberg DA, Hellner K, Sawyer J, Grace M, Li W, Harlow E, Munger K. Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proceedings of the National Academy of Sciences of the United States of America. 107: 12463-8. PMID 20616055 DOI: 10.1073/Pnas.1007462107  0.392
2009 Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, Morgan DO, Tsai LH, Wolgemuth DJ. Cyclin-dependent kinases: a family portrait. Nature Cell Biology. 11: 1275-6. PMID 19884882 DOI: 10.1038/Ncb1109-1275  0.585
2008 Baldwin A, Li W, Grace M, Pearlberg J, Harlow E, Münger K, Grueneberg DA. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 16478-83. PMID 18948598 DOI: 10.1073/Pnas.0806195105  0.335
2008 Grueneberg DA, Li W, Davies JE, Sawyer J, Pearlberg J, Harlow E. Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proceedings of the National Academy of Sciences of the United States of America. 105: 16490-5. PMID 18948597 DOI: 10.1073/Pnas.0806578105  0.382
2008 Bommi-Reddy A, Almeciga I, Sawyer J, Geisen C, Li W, Harlow E, Kaelin WG, Grueneberg DA. Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proceedings of the National Academy of Sciences of the United States of America. 105: 16484-9. PMID 18948595 DOI: 10.1073/Pnas.0806574105  0.357
2008 Grueneberg DA, Degot S, Pearlberg J, Li W, Davies JE, Baldwin A, Endege W, Doench J, Sawyer J, Hu Y, Boyce F, Xian J, Munger K, Harlow E. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proceedings of the National Academy of Sciences of the United States of America. 105: 16472-7. PMID 18948591 DOI: 10.1073/Pnas.0808019105  0.381
2007 Hu Y, Rolfs A, Bhullar B, Murthy TV, Zhu C, Berger MF, Camargo AA, Kelley F, McCarron S, Jepson D, Richardson A, Raphael J, Moreira D, Taycher E, Zuo D, ... ... Harlow E, et al. Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Research. 17: 536-43. PMID 17322287 DOI: 10.1101/Gr.6037607  0.352
2006 Harlow E, Lane D. Immunoprecipitation: purifying the immune complexes. Csh Protocols. 2006. PMID 22485918 DOI: 10.1101/pdb.prot4536  0.331
2006 Harlow E, Lane D. Immunoprecipitation: denaturing lysis. Csh Protocols. 2006. PMID 22485916 DOI: 10.1101/pdb.prot4534  0.329
2006 Harlow E, Lane D. Immunoprecipitation: lysing yeast cells using glass beads. Csh Protocols. 2006. PMID 22485915 DOI: 10.1101/pdb.prot4533  0.329
2006 Harlow E, Lane D. Lysing tissue-culture cells for immunoprecipitation. Csh Protocols. 2006. PMID 22485913 DOI: 10.1101/pdb.prot4531  0.321
2006 Harlow E, Lane D. Antibody Addition and Detection for Staining Caenorhabditis elegans. Csh Protocols. 2006. PMID 22485905 DOI: 10.1101/pdb.prot4523  0.31
2006 Harlow E, Lane D. Immunoblotting: preparing immunoprecipitated proteins. Csh Protocols. 2006. PMID 22485848 DOI: 10.1101/pdb.prot4300  0.345
2006 Harlow E, Lane D. Immunoblotting: preparing cell lysates. Csh Protocols. 2006. PMID 22485847 DOI: 10.1101/pdb.prot4299  0.323
2006 Harlow E, Lane D. Fixing suspension cells with paraformaldehyde. Csh Protocols. 2006. PMID 22485843 DOI: 10.1101/pdb.prot4295  0.31
2006 Harlow E, Lane D. Fixing attached cells in paraformaldehyde. Csh Protocols. 2006. PMID 22485842 DOI: 10.1101/pdb.prot4294  0.316
2006 Harlow E, Lane D. Attaching suspension cells to slides using a cytocentrifuge. Csh Protocols. 2006. PMID 22485839 DOI: 10.1101/pdb.prot4291  0.311
2006 Harlow E, Lane D. Growing adherent cells on coverslips or multiwell slides. Csh Protocols. 2006. PMID 22485837 DOI: 10.1101/pdb.prot4289  0.3
2006 Harlow E, Lane D. Protein Quantitation: UV Detection. Csh Protocols. 2006. PMID 22485683 DOI: 10.1101/pdb.prot4307  0.311
2006 Harlow E, Lane D. Protein quantitation: bradford spot test. Csh Protocols. 2006. PMID 22485682 DOI: 10.1101/pdb.prot4306  0.302
2006 Harlow E, Lane D. Antibody purification on protein a or protein g columns. Csh Protocols. 2006. PMID 22485675 DOI: 10.1101/pdb.prot4283  0.343
2006 Harlow E, Lane D. Staining immunoblots for total protein using India ink. Csh Protocols. 2006. PMID 22485667 DOI: 10.1101/pdb.prot4270  0.344
2006 Harlow E, Lane D. Staining immunoblots for total protein using ponceau s. Csh Protocols. 2006. PMID 22485666 DOI: 10.1101/pdb.prot4269  0.328
2005 Pearlberg J, Degot S, Endege W, Park J, Davies J, Gelfand E, Sawyer J, Conery A, Doench J, Li W, Gonzalez L, Boyce FM, Brizuela L, Labaer J, Grueneberg D, ... Harlow E, et al. Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells. Cold Spring Harbor Symposia On Quantitative Biology. 70: 449-59. PMID 16869783 DOI: 10.1101/Sqb.2005.70.047  0.359
2005 Park J, Hu Y, Murthy TV, Vannberg F, Shen B, Rolfs A, Hutti JE, Cantley LC, Labaer J, Harlow E, Brizuela L. Building a human kinase gene repository: bioinformatics, molecular cloning, and functional validation. Proceedings of the National Academy of Sciences of the United States of America. 102: 8114-9. PMID 15928075 DOI: 10.1073/Pnas.0503141102  0.377
2004 Johnson BR, Nitta RT, Frock RL, Mounkes L, Barbie DA, Stewart CL, Harlow E, Kennedy BK. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proceedings of the National Academy of Sciences of the United States of America. 101: 9677-82. PMID 15210943 DOI: 10.1073/Pnas.0403250101  0.732
2004 Barbie DA, Kudlow BA, Frock R, Zhao J, Johnson BR, Dyson N, Harlow E, Kennedy BK. Nuclear reorganization of mammalian DNA synthesis prior to cell cycle exit. Molecular and Cellular Biology. 24: 595-607. PMID 14701733 DOI: 10.1128/Mcb.24.2.595-607.2004  0.757
2003 Kohn MJ, Bronson RT, Harlow E, Dyson NJ, Yamasaki L. Dp1 is required for extra-embryonic development. Development (Cambridge, England). 130: 1295-305. PMID 12588846 DOI: 10.1242/Dev.00355  0.621
2002 Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nature Reviews. Cancer. 2: 910-7. PMID 12459729 DOI: 10.1038/nrc950  0.383
2002 Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes & Development. 16: 1472-87. PMID 12080086 DOI: 10.1101/Gad.995802  0.368
2002 Braun P, Hu Y, Shen B, Halleck A, Koundinya M, Harlow E, LaBaer J. Proteome-scale purification of human proteins from bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 2654-9. PMID 11880620 DOI: 10.1073/Pnas.042684199  0.359
2001 Kennedy BK, Liu OW, Dick FA, Dyson N, Harlow E, Vidal M. Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proceedings of the National Academy of Sciences of the United States of America. 98: 8720-5. PMID 11447271 DOI: 10.1073/Pnas.151240898  0.672
2001 Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, Lane WS, Reinberg D, Harlow E, Branton PE. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Molecular and Cellular Biology. 21: 2918-32. PMID 11283269 DOI: 10.1128/Mcb.21.8.2918-2932.2001  0.411
2001 Stevenson LF, Kennedy BK, Harlow E. A large-scale overexpression screen in Saccharomyces cerevisiae identifies previously uncharacterized cell cycle genes. Proceedings of the National Academy of Sciences of the United States of America. 98: 3946-51. PMID 11274415 DOI: 10.1073/Pnas.051013498  0.663
2000 Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes & Development. 14: 2855-68. PMID 11090133 DOI: 10.1101/Gad.842600  0.607
2000 Classon M, Kennedy BK, Mulloy R, Harlow E. Opposing roles of pRB and p107 in adipocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America. 97: 10826-31. PMID 10995476 DOI: 10.1073/Pnas.190343597  0.397
2000 Classon M, Salama S, Gorka C, Mulloy R, Braun P, Harlow E. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proceedings of the National Academy of Sciences of the United States of America. 97: 10820-5. PMID 10995475 DOI: 10.1073/pnas.190343497  0.452
2000 Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, Harlow E. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes & Development. 14: 2283-97. PMID 10995386 DOI: 10.1101/Gad.827700  0.361
1999 McCaffrey J, Yamasaki L, Dyson NJ, Harlow E, Griep AE. Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1. Molecular and Cellular Biology. 19: 6458-68. PMID 10454591 DOI: 10.1128/Mcb.19.9.6458  0.61
1999 Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, Harlow E, Yamasaki L, Farnham PJ. No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Molecular Carcinogenesis. 25: 295-303. PMID 10449036 DOI: 10.1002/(Sici)1098-2744(199908)25:4<295::Aid-Mc8>3.0.Co;2-9  0.576
1998 Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Molecular Cell. 2: 283-92. PMID 9774967 DOI: 10.1016/S1097-2765(00)80273-7  0.587
1998 Harrington EA, Bruce JL, Harlow E, Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 95: 11945-50. PMID 9751770 DOI: 10.1073/Pnas.95.20.11945  0.543
1998 Schulman BA, Lindstrom DL, Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proceedings of the National Academy of Sciences of the United States of America. 95: 10453-8. PMID 9724724 DOI: 10.1073/Pnas.95.18.10453  0.617
1998 Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nature Genetics. 18: 360-4. PMID 9537419 DOI: 10.1038/Ng0498-360  0.597
1998 Zhao J, Dynlacht B, Imai T, Hori T, Harlow E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes & Development. 12: 456-61. PMID 9472014 DOI: 10.1101/Gad.12.4.456  0.37
1997 Dynlacht BD, Ngwu C, Winston J, Swindell EC, Elledge SJ, Harlow E, Harper JW. Purification and analysis of CIP/KIP proteins. Methods in Enzymology. 283: 230-44. PMID 9251023 DOI: 10.1016/S0076-6879(97)83019-4  0.428
1997 Dynlacht BD, Moberg K, Lees JA, Harlow E, Zhu L. Specific regulation of E2F family members by cyclin-dependent kinases. Molecular and Cellular Biology. 17: 3867-75. PMID 9199321 DOI: 10.1128/Mcb.17.7.3867  0.386
1997 LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes & Development. 11: 847-62. PMID 9106657 DOI: 10.1101/Gad.11.7.847  0.692
1997 Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proceedings of the National Academy of Sciences of the United States of America. 94: 3302-7. PMID 9096388 DOI: 10.1073/Pnas.94.7.3302  0.348
1997 Zarkowska T, U S, Harlow E, Mittnacht S. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene. 14: 249-54. PMID 9010227 DOI: 10.1038/sj.onc.1200824  0.381
1996 Magae J, Wu CL, Illenye S, Harlow E, Heintz NH. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. Journal of Cell Science. 109: 1717-26. PMID 8832394  0.307
1996 Vidal M, Braun P, Chen E, Boeke JD, Harlow E. Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proceedings of the National Academy of Sciences of the United States of America. 93: 10321-6. PMID 8816798 DOI: 10.1073/Pnas.93.19.10321  0.55
1996 Vidal M, Brachmann RK, Fattaey A, Harlow E, Boeke JD. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proceedings of the National Academy of Sciences of the United States of America. 93: 10315-20. PMID 8816797 DOI: 10.1073/Pnas.93.19.10315  0.562
1996 Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood. 88: 268-76. PMID 8704183 DOI: 10.1182/Blood.V88.1.268.268  0.612
1996 Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes & Development. 10: 1633-44. PMID 8682294 DOI: 10.1101/Gad.10.13.1633  0.594
1996 Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. Targeted disruption of p107: functional overlap between p107 and Rb. Genes & Development. 10: 1621-32. PMID 8682293 DOI: 10.1101/Gad.10.13.1621  0.573
1996 Wu CL, Classon M, Dyson N, Harlow E. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Molecular and Cellular Biology. 16: 3698-706. PMID 8668186 DOI: 10.1128/Mcb.16.7.3698  0.624
1996 Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 85: 537-48. PMID 8653789 DOI: 10.1016/S0092-8674(00)81254-4  0.591
1995 Koh J, Enders GH, Dynlacht BD, Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375: 506-10. PMID 7777061 DOI: 10.1038/375506A0  0.438
1995 Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. The Embo Journal. 14: 1904-13. PMID 7743997 DOI: 10.1002/J.1460-2075.1995.Tb07182.X  0.4
1995 Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA. In vivo association of E2F and DP family proteins. Molecular and Cellular Biology. 15: 2536-46. PMID 7739537 DOI: 10.1128/Mcb.15.5.2536  0.418
1995 Wade M, Blake MC, Jambou RC, Helin K, Harlow E, Azizkhan JC. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene. The Journal of Biological Chemistry. 270: 9783-91. PMID 7730357 DOI: 10.1074/jbc.270.17.9783  0.347
1995 Zhu L, Harlow E, Dynlacht BD. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes & Development. 9: 1740-52. PMID 7622038 DOI: 10.1101/Gad.9.14.1740  0.397
1994 Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, Weinberg RA. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. The Embo Journal. 13: 118-27. PMID 8306955 DOI: 10.1002/J.1460-2075.1994.Tb06241.X  0.406
1994 Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Molecular and Cellular Biology. 14: 2077-86. PMID 8114739 DOI: 10.1128/Mcb.14.3.2077  0.378
1994 Tsai LH, Delalle I, Caviness VS, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 371: 419-23. PMID 8090221 DOI: 10.1038/371419A0  0.555
1994 Helin K, Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. Journal of Virology. 68: 5027-35. PMID 8035503 DOI: 10.1128/Jvi.68.8.5027-5035.1994  0.403
1994 Dynlacht BD, Flores O, Lees JA, Harlow E. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes & Development. 8: 1772-86. PMID 7958856 DOI: 10.1101/Gad.8.15.1772  0.411
1994 Zhu L, Enders GH, Wu CL, Starz MA, Moberg KH, Lees JA, Dyson N, Harlow E. Growth suppression by members of the retinoblastoma protein family. Cold Spring Harbor Symposia On Quantitative Biology. 59: 75-84. PMID 7587134 DOI: 10.1101/Sqb.1994.059.01.011  0.563
1993 Tsai LH, Lees E, Faha B, Harlow E, Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene. 8: 1593-602. PMID 8502482  0.501
1993 Lees EM, Harlow E. Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Molecular and Cellular Biology. 13: 1194-201. PMID 8423786 DOI: 10.1128/Mcb.13.2.1194  0.384
1993 Fattaey AR, Helin K, Dembski MS, Dyson N, Harlow E, Vuocolo GA, Hanobik MG, Haskell KM, Oliff A, Defeo-Jones D. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene. 8: 3149-56. PMID 8414517  0.314
1993 Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Molecular and Cellular Biology. 13: 6501-8. PMID 8413249 DOI: 10.1128/Mcb.13.10.6501  0.425
1993 Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes & Development. 7: 1850-61. PMID 8405995 DOI: 10.1101/Gad.7.10.1850  0.419
1993 Faha B, Harlow E, Lees E. The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. Journal of Virology. 67: 2456-65. PMID 8386263 DOI: 10.1128/Jvi.67.5.2456-2465.1993  0.435
1993 Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Development. 7: 1111-25. PMID 8319904 DOI: 10.1101/Gad.7.7A.1111  0.632
1993 Tsai LH, Takahashi T, Caviness VS, Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (Cambridge, England). 119: 1029-40. PMID 8306873  0.493
1993 van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science (New York, N.Y.). 262: 2050-4. PMID 8266103 DOI: 10.1126/Science.8266103  0.394
1993 Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. The retinoblastoma protein binds to a family of E2F transcription factors. Molecular and Cellular Biology. 13: 7813-25. PMID 8246996 DOI: 10.1128/Mcb.13.12.7813  0.712
1993 Fattaey AR, Harlow E, Helin K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Molecular and Cellular Biology. 13: 7267-77. PMID 8246949 DOI: 10.1128/Mcb.13.12.7267  0.427
1993 Fattaey A, Helin K, Harlow E. Transcriptional inhibition by the retinoblastoma protein. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 340: 333-6. PMID 8103936 DOI: 10.1098/rstb.1993.0075  0.451
1992 Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH. A family of human cdc2-related protein kinases. The Embo Journal. 11: 2909-17. PMID 1639063 DOI: 10.1002/J.1460-2075.1992.Tb05360.X  0.593
1992 Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 70: 337-50. PMID 1638634 DOI: 10.1016/0092-8674(92)90107-N  0.706
1992 Hu QJ, Lees JA, Buchkovich KJ, Harlow E. The retinoblastoma protein physically associates with the human cdc2 kinase. Molecular and Cellular Biology. 12: 971-80. PMID 1545827 DOI: 10.1128/Mcb.12.3.971  0.404
1992 Dyson N, Guida P, McCall C, Harlow E. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. Journal of Virology. 66: 4606-11. PMID 1534854 DOI: 10.1128/Jvi.66.7.4606-4611.1992  0.565
1992 Faha B, Ewen ME, Tsai LH, Livingston DM, Harlow E. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (New York, N.Y.). 255: 87-90. PMID 1532458 DOI: 10.1126/Science.1532458  0.617
1992 Ewen ME, Faha B, Harlow E, Livingston DM. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (New York, N.Y.). 255: 85-7. PMID 1532457 DOI: 10.1126/Science.1532457  0.399
1992 Cao L, Faha B, Dembski M, Tsai LH, Harlow E, Dyson N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature. 355: 176-9. PMID 1530885 DOI: 10.1038/355176A0  0.722
1992 Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes & Development. 6: 1874-85. PMID 1398067 DOI: 10.1101/GAD.6.10.1874  0.382
1992 Dyson N, Guida P, Münger K, Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. Journal of Virology. 66: 6893-902. PMID 1331501 DOI: 10.1128/Jvi.66.12.6893-6902.1992  0.637
1992 Meyerson M, Enders G, Wu C, Su L, Gorka C, Nelson C, Harlow E, Tsai L. A family of human cdc2-related protein kinases. The Embo Journal. 11: 2909-2917. DOI: 10.1002/j.1460-2075.1992.tb05360.x  0.466
1991 Larose A, Dyson N, Sullivan M, Harlow E, Bastin M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. Journal of Virology. 65: 2308-13. PMID 2016761 DOI: 10.1128/Jvi.65.5.2308-2313.1991  0.587
1991 Meyerson M, Faha B, Su LK, Harlow E, Tsai LH. The cyclin-dependent kinase family. Cold Spring Harbor Symposia On Quantitative Biology. 56: 177-86. PMID 1840251 DOI: 10.1101/Sqb.1991.056.01.023  0.491
1991 Herrmann CH, Su LK, Harlow E. Adenovirus E1A is associated with a serine/threonine protein kinase. Journal of Virology. 65: 5848-59. PMID 1833561 DOI: 10.1128/Jvi.65.11.5848-5859.1991  0.383
1991 Lees JA, Buchkovich KJ, Marshak DR, Anderson CW, Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. The Embo Journal. 10: 4279-90. PMID 1756735 DOI: 10.1002/J.1460-2075.1991.Tb05006.X  0.409
1991 Hu QJ, Bautista C, Edwards GM, Defeo-Jones D, Jones RE, Harlow E. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Molecular and Cellular Biology. 11: 5792-9. PMID 1717832 DOI: 10.1128/Mcb.11.11.5792  0.438
1991 Giordano A, Lee JH, Scheppler JA, Herrmann C, Harlow E, Deuschle U, Beach D, Franza BR. Cell cycle regulation of histone H1 kinase activity associated with the adenoviral protein E1A. Science (New York, N.Y.). 253: 1271-5. PMID 1653969 DOI: 10.1126/Science.1653969  0.453
1991 Tsai LH, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature. 353: 174-7. PMID 1653904 DOI: 10.1038/353174A0  0.595
1990 Lee CC, Craigen WJ, Muzny DM, Harlow E, Caskey CT. Cloning and expression of a mammalian peptide chain release factor with sequence similarity to tryptophanyl-tRNA synthetases. Proceedings of the National Academy of Sciences of the United States of America. 87: 3508-12. PMID 2185472 DOI: 10.1073/Pnas.87.9.3508  0.324
1990 Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, Vandyke T, Harlow E. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. Journal of Virology. 64: 1353-6. PMID 2154613 DOI: 10.1128/Jvi.64.3.1353-1356.1990  0.597
1990 Buchkovich K, Dyson N, Whyte P, Harlow E. Cellular proteins that are targets for transformation by DNA tumour viruses. Ciba Foundation Symposium. 150: 262-71; discussion 2. PMID 2142644  0.342
1990 Hu QJ, Dyson N, Harlow E. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. The Embo Journal. 9: 1147-55. PMID 2138977 DOI: 10.1002/J.1460-2075.1990.Tb08221.X  0.642
1989 Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 58: 1097-105. PMID 2673543 DOI: 10.1016/0092-8674(89)90508-4  0.434
1989 Giordano A, Whyte P, Harlow E, Franza BR, Beach D, Draetta G. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell. 58: 981-90. PMID 2570639 DOI: 10.1016/0092-8674(89)90949-5  0.432
1989 Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. The Embo Journal. 8: 4099-105. PMID 2556261 DOI: 10.1002/J.1460-2075.1989.Tb08594.X  0.56
1989 Dyson N, Buchkovich K, Whyte P, Harlow E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell. 58: 249-55. PMID 2546678 DOI: 10.1016/0092-8674(89)90839-8  0.597
1989 Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (New York, N.Y.). 243: 934-7. PMID 2537532 DOI: 10.1126/Science.2537532  0.61
1989 Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E, Weinberg RA, Dryja TP. Point mutational inactivation of the retinoblastoma antioncogene. Science (New York, N.Y.). 243: 937-40. PMID 2521957 DOI: 10.1126/Science.2521957  0.364
1989 Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell. 56: 67-75. PMID 2521301 DOI: 10.1016/0092-8674(89)90984-7  0.367
1988 Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature. 334: 124-9. PMID 2968522 DOI: 10.1038/334124A0  0.389
1988 Horowitz JM, Friend SH, Weinberg RA, Whyte P, Buchkovich K, Harlow E. Anti-oncogenes and the negative regulation of cell growth. Cold Spring Harbor Symposia On Quantitative Biology. 53: 843-7. PMID 2908198 DOI: 10.1101/Sqb.1988.053.01.096  0.358
1986 Harlow E, Whyte P, Franza BR, Schley C. Association of adenovirus early-region 1A proteins with cellular polypeptides. Molecular and Cellular Biology. 6: 1579-89. PMID 2431282 DOI: 10.1128/Mcb.6.5.1579  0.34
1985 Harlow E, Williamson NM, Ralston R, Helfman DM, Adams TE. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Molecular and Cellular Biology. 5: 1601-10. PMID 3894933 DOI: 10.1128/mcb.5.7.1601-1610.1985  0.315
1985 Harlow E, Franza BR, Schley C. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. Journal of Virology. 55: 533-46. PMID 3894685 DOI: 10.1128/Jvi.55.3.533-546.1985  0.346
1983 Leppard K, Totty N, Waterfield M, Harlow E, Jenkins J, Crawford L. Purification and partial amino acid sequence analysis of the cellular tumour antigen, p53, from mouse SV40-transformed cells. The Embo Journal. 2: 1993-9. PMID 6315411 DOI: 10.1002/J.1460-2075.1983.Tb01690.X  0.301
1982 Lane D, Harlow E. Two different viral transforming proteins bind the same host tumour antigen. Nature. 298: 517. PMID 7048105 DOI: 10.1038/298517A0  0.321
1982 Crawford L, Leppard K, Lane D, Harlow E. Cellular proteins reactive with monoclonal antibodies directed against simian virus 40 T-antigen. Journal of Virology. 42: 612-20. PMID 6177872 DOI: 10.1128/Jvi.42.2.612-620.1982  0.335
1981 McCormick F, Clark R, Harlow E, Tjian R. SV40 T antigen binds specifically to a cellular 53 K protein in vitro. Nature. 292: 63-5. PMID 6268984 DOI: 10.1038/292063A0  0.345
1981 Harlow E, Pim DC, Crawford LV. Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells. Journal of Virology. 37: 564-73. PMID 6163871 DOI: 10.1128/Jvi.37.2.564-573.1981  0.363
Low-probability matches (unlikely to be authored by this person)
1981 Harlow E, Crawford LV, Pim DC, Williamson NM. Monoclonal antibodies specific for simian virus 40 tumor antigens. Journal of Virology. 39: 861-9. PMID 6169844 DOI: 10.1128/Jvi.39.3.861-869.1981  0.297
2006 Harlow E, Lane D. Immunoaffinity purification: coupling antibodies to protein a or g bead columns. Csh Protocols. 2006. PMID 22485679 DOI: 10.1101/pdb.prot4303  0.296
2006 Harlow E, Lane D. Immunoprecipitation: preclearing the lysate. Csh Protocols. 2006. PMID 22485917 DOI: 10.1101/pdb.prot4535  0.293
1980 McCormick F, Harlow E. Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. Journal of Virology. 34: 213-24. PMID 6246255 DOI: 10.1128/Jvi.34.1.213-224.1980  0.293
2006 Harlow E, Lane D. Attaching suspension cells to slides using chemical linkers. Csh Protocols. 2006. PMID 22485840 DOI: 10.1101/pdb.prot4292  0.292
1988 Whyte P, Ruley HE, Harlow E. Two regions of the adenovirus early region 1A proteins are required for transformation. Journal of Virology. 62: 257-65. PMID 2960834 DOI: 10.1128/Jvi.62.1.257-265.1988  0.29
2011 Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H, Harlow E, LaBaer J. High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proceedings of the National Academy of Sciences of the United States of America. 108: 2058-63. PMID 21233418 DOI: 10.1073/Pnas.1018157108  0.286
1987 Stephens C, Harlow E. Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. The Embo Journal. 6: 2027-35. PMID 2958276 DOI: 10.1002/J.1460-2075.1987.Tb02467.X  0.284
2009 Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Harlow E, LaBaer J. Autophagy and Tamoxifen Resistance in Breast Cancer. Cancer Research. 69: 5135-5135. DOI: 10.1158/0008-5472.Sabcs-09-5135  0.284
2006 Harlow E, Lane D. Immunoblotting: preparing protein solutions. Csh Protocols. 2006. PMID 22485846 DOI: 10.1101/pdb.prot4298  0.282
1986 Pallas DC, Schley C, Mahoney M, Harlow E, Schaffhausen BS, Roberts TM. Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. Journal of Virology. 60: 1075-84. PMID 3023660 DOI: 10.1128/Jvi.60.3.1075-1084.1986  0.281
2006 Harlow E, Lane D. Growing adherent cells directly on tissue dishes. Csh Protocols. 2006. PMID 22485838 DOI: 10.1101/pdb.prot4290  0.28
1997 Harlow E. Regulation of the mammalian proliferation by the retinoblastoma protein Faseb Journal. 11: A1014.  0.279
1989 Dyson N, Buchkovich K, Whyte P, Harlow E. Cellular proteins that are targetted by DNA tumor viruses for transformation. Princess Takamatsu Symposia. 20: 191-8. PMID 2488232  0.278
1996 Enders GH, Koh J, Missero C, Rustgi AK, Harlow E. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene. 12: 1239-45. PMID 8649826  0.276
1982 Crawford L, Harlow E. Uniform nomenclature for monoclonal antibodies directed against virus-coded proteins of simian virus 40 and polyoma virus. Journal of Virology. 41: 709. PMID 6281480 DOI: 10.1128/Jvi.41.2.709-709.1982  0.272
1992 Dyson N, Harlow E. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surveys. 12: 161-95. PMID 1353412  0.27
1996 Zukerberg L, Benedict W, Arnold A, Dyson N, Harlow E, Harris N. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1 Blood. 88: 268-276. DOI: 10.1182/blood.v88.1.268.bloodjournal881268  0.266
2006 Harlow E, Lane D. Immunoprecipitation: lysing bacteria by sonication. Csh Protocols. 2006. PMID 22485914 DOI: 10.1101/pdb.prot4532  0.265
2006 Harlow E, Lane D. Immunoaffinity purification: binding of antigen to antibody-bead matrix in a suspension. Csh Protocols. 2006. PMID 22485672 DOI: 10.1101/pdb.prot4275  0.263
2006 Harlow E, Lane D. Unmasking hidden epitopes with proteases. Csh Protocols. 2006. PMID 22485910 DOI: 10.1101/pdb.prot4528  0.263
2006 Harlow E, Lane D. Immunoaffinity purification: binding of antigen to antibody-bead matrix in a column. Csh Protocols. 2006. PMID 22485671 DOI: 10.1101/pdb.prot4274  0.261
2006 Harlow E, Lane D. Preparing cell smears from tissue samples for immunostaining. Csh Protocols. 2006. PMID 22485706 DOI: 10.1101/pdb.prot4330  0.261
2006 Harlow E, Lane D. Immunoblotting: submerged electrophoretic transfer of proteins from gels to membranes. Csh Protocols. 2006. PMID 22485678 DOI: 10.1101/pdb.prot4302  0.26
2006 Harlow E, Lane D. Binding antibodies to tissue sections. Csh Protocols. 2006. PMID 22485707 DOI: 10.1101/pdb.prot4331  0.258
2006 Harlow E, Lane D. Fixing attached cells in organic solvents. Csh Protocols. 2006. PMID 22485841 DOI: 10.1101/pdb.prot4293  0.258
1995 Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E, Look AT. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics. 25: 130-8. PMID 7774910 DOI: 10.1016/0888-7543(95)80118-6  0.252
2006 Harlow E, Lane D. Antibody addition to Drosophila specimens and detection using fluorochrome-linked reagents. Csh Protocols. 2006. PMID 22485909 DOI: 10.1101/pdb.prot4527  0.252
1995 Zhu L, Enders G, Lees J, Beijersbergen R, Bernards R, Harlow E. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. The Embo Journal. 14: 1904-1913. DOI: 10.1002/j.1460-2075.1995.tb07182.x  0.25
2006 Harlow E, Lane D. Unmasking hidden epitopes using the microwave oven. Csh Protocols. 2006. PMID 22485911 DOI: 10.1101/pdb.prot4529  0.246
2006 Harlow E, Lane D. Fixing Caenorhabditis elegans in Bouin's fixative. Csh Protocols. 2006. PMID 22485903 DOI: 10.1101/pdb.prot4521  0.244
2006 Harlow E, Lane D. Storage of purified antibodies. Csh Protocols. 2006. PMID 22485674 DOI: 10.1101/pdb.prot4282  0.243
2006 Harlow E, Lane D. Purification of antibodies on an antigen column. Csh Protocols. 2006. PMID 22485676 DOI: 10.1101/pdb.prot4284  0.242
2006 Harlow E, Lane D. Unmasking hidden epitopes using the pressure cooker. Csh Protocols. 2006. PMID 22485912 DOI: 10.1101/pdb.prot4530  0.242
2006 Harlow E, Lane D. Labeling monoclonal antibodies by biosynthesis. Csh Protocols. 2006. PMID 22485801 DOI: 10.1101/pdb.prot4288  0.238
2006 Harlow E, Lane D. Labeling antibodies with biotin. Csh Protocols. 2006. PMID 22485799 DOI: 10.1101/pdb.prot4286  0.237
2006 Harlow E, Lane D. Labeling antibodies with fluorochromes. Csh Protocols. 2006. PMID 22485798 DOI: 10.1101/pdb.prot4285  0.235
2006 Harlow E, Lane D. Immunoblotting: antigen detection using chemiluminescence. Csh Protocols. 2006. PMID 22485668 DOI: 10.1101/pdb.prot4271  0.235
2006 Harlow E, Lane D. Immunoaffinity purification: eluting antigens from immunoaffinity columns. Csh Protocols. 2006. PMID 22485673 DOI: 10.1101/pdb.prot4276  0.233
2006 Harlow E, Lane D. Immunoaffinity purification: coupling antibodies to activated beads. Csh Protocols. 2006. PMID 22485680 DOI: 10.1101/pdb.prot4304  0.232
2006 Harlow E, Lane D. Immunoblotting: antigen detection using chromogenic methods. Csh Protocols. 2006. PMID 22485669 DOI: 10.1101/pdb.prot4272  0.231
2006 Harlow E, Lane D. Detection of alkaline phosphatase-labeled reagents. Csh Protocols. 2006. PMID 22485711 DOI: 10.1101/pdb.prot4335  0.228
1991 Lees J, Buchkovich K, Marshak D, Anderson C, Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. The Embo Journal. 10: 4279-4290. DOI: 10.1002/j.1460-2075.1991.tb05006.x  0.226
1997 Haber D, Harlow E. Tumour-suppressor genes: evolving definitions in the genomic age. Nature Genetics. 16: 320-2. PMID 9241260 DOI: 10.1038/Ng0897-320  0.223
2009 Li W, Bhattacharya N, Boyce FM, Gupta P, Watnick RS, Harlow EE. Abstract A200: Differential kinase requirements of human cell lines pertaining to metastasis and c‐Met signaling Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A200  0.223
2006 Harlow E, Lane D. Antibody addition to Drosophila specimens and detection using enzyme-linked reagents. Csh Protocols. 2006. PMID 22485908 DOI: 10.1101/pdb.prot4526  0.22
2006 Harlow E, Lane D. Storage of sera. Csh Protocols. 2006. PMID 22485795 DOI: 10.1101/pdb.prot4279  0.217
2006 Harlow E, Lane D. Indirect detection using fluorochrome-labeled reagents. Csh Protocols. 2006. PMID 22485845 DOI: 10.1101/pdb.prot4297  0.215
2006 Harlow E, Lane D. Indirect detection using horseradish peroxidase-labeled reagents. Csh Protocols. 2006. PMID 22485844 DOI: 10.1101/pdb.prot4296  0.214
1996 Harlow E. A research shortcut from a common cold virus to human cancer. Cancer. 78: 558-65. PMID 8697405 DOI: 10.1002/(SICI)1097-0142(19960801)78:3<558::AID-CNCR26>3.0.CO;2-X  0.212
2006 Harlow E, Lane D. Detection of horseradish peroxidase-labeled reagents with aminoethylcarbazole. Csh Protocols. 2006. PMID 22485710 DOI: 10.1101/pdb.prot4334  0.212
2006 Harlow E, Lane D. Detection of horseradish peroxidase-labeled reagents with chloronaphthol. Csh Protocols. 2006. PMID 22485709 DOI: 10.1101/pdb.prot4333  0.212
2006 Harlow E, Lane D. Stripping immunoblots for reprobing or storage. Csh Protocols. 2006. PMID 22485670 DOI: 10.1101/pdb.prot4273  0.211
2006 Harlow E, Lane D. Epitope mapping by competition assay. Csh Protocols. 2006. PMID 22485793 DOI: 10.1101/pdb.prot4277  0.21
2006 Harlow E, Lane D. Preparing late whole-mount Drosophila embryos for immunostaining. Csh Protocols. 2006. PMID 22485907 DOI: 10.1101/pdb.prot4525  0.208
2006 Harlow E, Lane D. Detection of gold-labeled reagents. Csh Protocols. 2006. PMID 22485713 DOI: 10.1101/pdb.prot4337  0.208
2006 Harlow E, Lane D. Epitope mapping using synthetic biotin-labeled peptides. Csh Protocols. 2006. PMID 22485794 DOI: 10.1101/pdb.prot4278  0.206
1989 Münger K, Werness B, Dyson N, Phelps W, Harlow E, Howley P. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. The Embo Journal. 8: 4099-4105. DOI: 10.1002/j.1460-2075.1989.tb08594.x  0.204
2006 Harlow E, Lane D. Detection of horseradish peroxidase-labeled reagents with diaminobenzidine/metal. Csh Protocols. 2006. PMID 22485708 DOI: 10.1101/pdb.prot4332  0.203
2006 Harlow E, Lane D. Preparing paraffin tissue sections for immunostaining. Csh Protocols. 2006. PMID 22485705 DOI: 10.1101/pdb.prot4329  0.199
2006 Harlow E, Lane D. Preparing frozen tissue sections for immunostaining. Csh Protocols. 2006. PMID 22485704 DOI: 10.1101/pdb.prot4328  0.199
2010 Vander Heiden MG, Christofk HR, Schuman E, Subtelny AO, Sharfi H, Harlow EE, Xian J, Cantley LC. Identification of small molecule inhibitors of pyruvate kinase M2. Biochemical Pharmacology. 79: 1118-24. PMID 20005212 DOI: 10.1016/J.Bcp.2009.12.003  0.199
2006 Harlow E, Lane D. Fixing Caenorhabditis elegans in Paraformaldehyde. Csh Protocols. 2006. PMID 22485904 DOI: 10.1101/pdb.prot4522  0.199
2006 Harlow E, Lane D. Storage of tissue culture supernatants. Csh Protocols. 2006. PMID 22485796 DOI: 10.1101/pdb.prot4280  0.194
2006 Harlow E, Lane D. Detection of β-Galactosidase-Labeled Reagents. Csh Protocols. 2006. PMID 22485712 DOI: 10.1101/pdb.prot4336  0.192
2006 Harlow E, Lane D. Storage of ascitic fluid. Csh Protocols. 2006. PMID 22485797 DOI: 10.1101/pdb.prot4281  0.189
2000 Mihich E, Harlow E. Twelfth annual Pezcoller symposium: signaling cross-talks in cancer cells. Cancer Research. 60: 7177-83. PMID 11156428  0.186
2012 Varmus H, Harlow E. Science funding: Provocative questions in cancer research. Nature. 481: 436-7. PMID 22281578 DOI: 10.1038/481436A  0.179
2006 Harlow E, Lane D. Mounting Samples in DPX. Csh Protocols. 2006. PMID 22485791 DOI: 10.1101/pdb.prot4460  0.175
2006 Harlow E, Lane D. Mounting samples in gelvatol or mowiol. Csh Protocols. 2006. PMID 22485792 DOI: 10.1101/pdb.prot4461  0.175
2006 Harlow E, Lane D. Preparing acetone powders. Csh Protocols. 2006. PMID 22485681 DOI: 10.1101/pdb.prot4305  0.175
1992 Harlow E. Retinoblastoma. For our eyes only. Nature. 359: 270-1. PMID 1406928 DOI: 10.1038/359270a0  0.171
1994 Mittnacht S, Lees J, Desai D, Harlow E, Morgan D, Weinberg R. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. The Embo Journal. 13: 118-127. DOI: 10.1002/j.1460-2075.1994.tb06241.x  0.166
2006 Harlow E, Lane D. Staining yeast. Csh Protocols. 2006. PMID 22485902 DOI: 10.1101/pdb.prot4520  0.145
1980 Crawford LV, Lane DP, Denhardt DT, Harlow EE, Nicklin PM, Osborn K, Pim DC. Characterization of the complex between SV40 large T antigen and the 53K host protein in transformed mouse cells. Cold Spring Harbor Symposia On Quantitative Biology. 44: 179-87. PMID 6253132 DOI: 10.1101/Sqb.1980.044.01.021  0.144
2001 Lee SB, Kim SH, Bell DW, Wahrer DC, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, Harlow E, Haber DA. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Research. 61: 8062-7. PMID 11719428  0.134
1992 Harlow E. Eleventh annual Sapporo Cancer Seminar. Connecting the dots: assembling the pathways that control cell division. Cancer Research. 52: 2362-6. PMID 1559240  0.118
2006 Harlow E, Lane D. Immunoblotting: semi-dry electrophoretic transfer of proteins from gels to membranes. Csh Protocols. 2006. PMID 22485677 DOI: 10.1101/pdb.prot4301  0.116
2005 Spector DL, Goldman RD, Leinwand LA, Harlow E, Lane D. Immunoblot affinity purification Nature Methods. 2. DOI: 10.1038/Nmeth1005-797  0.103
2012 Till SM, Wijetunge LS, Seidel VG, Harlow E, Wright AK, Bagni C, Contractor A, Gillingwater TH, Kind PC. Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Human Molecular Genetics. 21: 2143-56. PMID 22328088 DOI: 10.1093/Hmg/Dds030  0.103
1995 Burger MM, Harlow E. UICC study group on basic and clinical cancer research: Cell-cycle control: A target for therapy? International Journal of Cancer. 63: 321-323. DOI: 10.1002/ijc.2910630302  0.099
2006 Harlow E, Lane D. Labeling antibodies with iodine. Csh Protocols. 2006. PMID 22485800 DOI: 10.1101/pdb.prot4287  0.083
2010 Harlow EG, Till SM, Russell TA, Wijetunge LS, Kind P, Contractor A. Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron. 65: 385-98. PMID 20159451 DOI: 10.1016/J.Neuron.2010.01.024  0.073
1951 HARLOW EF. A DNA changes its sterilization technics. Public Health Nursing. 43: 129-31; passim. PMID 14844576  0.065
2006 Harlow E, Lane D. Bradford assay. Csh Protocols. 2006. PMID 22485992 DOI: 10.1101/pdb.prot4644  0.064
2006 Harlow E, Lane D. Preparing early whole-mount Drosophila embryos for immunostaining. Csh Protocols. 2006. PMID 22485906 DOI: 10.1101/pdb.prot4524  0.048
2015 Rajaraman P, Dey B, Majumder PP, Mayor S, Pillai MR, Ramaswamy S, Shaha C, Johnson M, Sivaram S, Trimble EL, Harlow EE, VijayRaghavan K. First International Workshopson Provocative Questions (PQ) in Cancer Research, October-November 2014, New Delhi, Bengaluru, and Thiruvananthapuram, India. Journal of Cancer Policy. 6: 33-36. PMID 26568911 DOI: 10.1016/j.jcpo.2015.10.001  0.037
2015 Masoudi A, Beamer BS, Harlow ER, Manoukian OS, Walley KC, Hertz B, Haeussler C, Olson JJ, Zurakowski D, Nazarian A, Ramappa AJ, DeAngelis JP. Biomechanical evaluation of an all-inside suture-based device for repairing longitudinal meniscal tears. Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 31: 428-34. PMID 25442653 DOI: 10.1016/j.arthro.2014.08.027  0.031
2015 Beamer BS, Masoudi A, Walley KC, Harlow ER, Manoukian OS, Hertz B, Haeussler C, Olson JJ, Deangelis JP, Nazarian A, Ramappa AJ. Analysis of a new all-inside versus inside-out technique for repairing radial meniscal tears. Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 31: 293-8. PMID 25312766 DOI: 10.1016/j.arthro.2014.08.011  0.028
2005 Lawler J, Harlow E. Postmodernization: A Phase We're Going Through? Management in Social Care British Journal of Social Work. 35: 1163-1174. DOI: 10.1093/bjsw/bch209  0.023
2007 Harlow E, Blackburn F. Fostering matters: A foster carer's perspective Social Work and Social Sciences Review. 13: 48-56. DOI: 10.1921/19650  0.022
2015 Probasco JC, Hawley G, Burnett M, Gibson L, Carter K, Harlow E, Russell H, Huffman L, Adams J, Ziegler T, Sporney H, Levy M, Puttgen HA. Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement Project. The Neurohospitalist. 5: 197-204. PMID 26425247 DOI: 10.1177/1941874415576206  0.018
2010 Shardlow SM, Harlow E. Academic affiliations of social work journal article authors from 1999-2003: A productivity analysis from the United Kingdom Journal of Social Service Research. 36: 377-384. DOI: 10.1080/01488376.2010.494088  0.017
2009 Harlow E. What percentage Strad? Strad. 120: 9.  0.017
1994 Harlow E. An introduction to the puzzle Cold Spring Harbor Symposia On Quantitative Biology. 59: 709-724.  0.016
2009 Harlow E. Eliciting narratives of teenage pregnancy in the UK: Reflexively exploring some of the methodological challenges Qualitative Social Work. 8: 211-228. DOI: 10.1177/1473325009103376  0.012
2015 DeAngelis JP, Hertz B, Wexler MT, Patel N, Walley KC, Harlow ER, Manoukian OS, Masoudi A, Vaziri A, Ramappa AJ, Nazarian A. Posterior Capsular Plication Constrains the Glenohumeral Joint by Drawing the Humeral Head Closer to the Glenoid and Resisting Abduction. Orthopaedic Journal of Sports Medicine. 3: 2325967115599347. PMID 26535390 DOI: 10.1177/2325967115599347  0.011
2015 Harlow E, Izod K. Guest Editorial Practice. 27: 235-238. DOI: 10.1080/09503153.2015.1048053  0.01
2015 Fishel F, Dowdle F, Harlow E, James T. Development of a statewide web-based pesticide applicator certification exam system Journal of Extension. 53.  0.01
2013 Harlow E, Berg E, Barry J, Chandler J. Neoliberalism, managerialism and the reconfiguring of social work in Sweden and the United Kingdom1 Organization. 20: 534-550. DOI: 10.1177/1350508412448222  0.01
2013 Harlow E. Coaching, Supervision and the Social Work Zeitgeist Practice. 25: 61-70. DOI: 10.1080/09503153.2013.775237  0.01
2011 Quinney A, Harlow E. Editorial Practice. 23: 67-68. DOI: 10.1080/09503153.2011.561553  0.01
2007 Harlow E, Frost N. Children of the state: Reforming the care system. New labour and corporate parenting Social Work and Social Sciences Review. 13: 7-17. DOI: 10.1921/19647  0.01
2007 Harlow E. Girl ... there was a time Triquarterly. 113.  0.01
2006 Harlow E, Lane D. Counterstains. Csh Protocols. 2006. PMID 22485714 DOI: 10.1101/pdb.prot4338  0.01
2006 Harlow E, Shardlow SM. Safeguarding children: Challenges to the effective operation of core groups Child and Family Social Work. 11: 65-72. DOI: 10.1111/j.1365-2206.2006.00392.x  0.01
1996 Harlow E. Postabortion contraceptive services scarce in Turkey. Avsc News (Association For Voluntary Surgical Contraception (U.S.)). 34: 5. PMID 12347476  0.01
1996 Harlow ED, Burton JL. What do general practitioners want from a dermatology department? The British Journal of Dermatology. 134: 313-8. PMID 8746348  0.01
1996 Harlow ED, Burton JL. What do general practitioners want from a dermatology department? | Was erwartet der allgemeinmediziner von einer dermatologischen abteilung? H+G Zeitschrift Fur Hautkrankheiten. 71: 149-154.  0.01
1982 Harlow EH. Polarization. Science (New York, N.Y.). 215: 1186-7. PMID 17757514 DOI: 10.1126/science.215.4537.1186  0.01
1956 Harlow ES, Greene CR. Some Comments on "Temperature Profiles Throughout Cigarettes, Cigars, and Pipes". Science (New York, N.Y.). 123: 226-7. PMID 17820259 DOI: 10.1126/science.123.3189.226  0.01
Hide low-probability matches.